April 28, 2012

Fraudulent Science: What’s Retracted, What’s Not

  Critics who deplore the commercialization of medical research have raised concerns about scientific fraud and misconduct

Read More
Fraudulent Science: What’s Retracted, What’s Not

April 28, 2012

Fraudulent Science: What’s Retracted, What Is Not

 Even as the corruption of science is no longer a dirty little secret, but is in plain

Read More
Fraudulent Science: What’s Retracted, What Is Not

May 14, 2011

POGO to NIH: Stop Academic Ghostwriting Pollution

POGO reminds the director of the National Institutes of Health (posted below) that taxpayers provide the NIH

Read More
POGO to NIH: Stop Academic Ghostwriting Pollution

November 30, 2010

Psychiatry Texbook Penned by Two Academic Leaders –GSK Ghosted

A letter of complaint, by the Project on Government Oversight (POGO) was sent to the director of

Read More
Psychiatry Texbook Penned by Two Academic Leaders –GSK Ghosted

September 23, 2010

Former Sen Finance Committee Investigator Speaks Out

"…what they’ve been doing for years is buying off doctors to sell their products and a doctor’s

Read More
Former Sen Finance Committee Investigator Speaks Out

June 21, 2010

NIH Needs Sunshine Law Enforcement

CORRECTED/ REVISED This is a follow-up to our Infomail about the revelations in an investigative report by

Read More
NIH Needs Sunshine Law Enforcement

June 17, 2010

NIH Reform Compromised By Chief NIMH Psychiatrist

An investigative report by The Chronicle of Higher Education (June 6, 2010) provided details about the surrreptitious

Read More
NIH Reform Compromised By Chief NIMH Psychiatrist

June 7, 2009

Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

FDA officials are ignoring the real world tragedies–drug-induced deaths of children. Unfortunately for the children, child psychiatrists

Read More
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

April 30, 2009

Senator Grassley Might Leave Finance Committee: A Break For Pharma?

The Hill , a newspaper covering congressional news, reports: "Sen. Chuck Grassley (Iowa) is considering leaving his

Read More
Senator Grassley Might Leave Finance Committee: A Break For Pharma?

April 17, 2009

Is the FDA Bipolar or Complicit in Legitimizing IIlegal Marketing?

NEWS BLAZE April 16,2009 By Martha Rosenberg Op-Ed Contributor Is the FDA Bipolar? In February the Justice

Read More
Is the FDA Bipolar or Complicit in Legitimizing IIlegal Marketing?

March 8, 2009

Psychiatrists On the Take: the Focus of Government Investigations

The Boston Globe reports (below): "a complaint unsealed last week in US District Court in Boston, prosecutors

Read More
Psychiatrists On the Take: the Focus of Government Investigations

December 29, 2008

Marcia Angell: Drug Co & Doctors: A Story of Corruption

Drug Companies & Doctors: A Story of Corruption By Marcia Angell, MD, former Editor in Chief of

Read More
Marcia Angell: Drug Co & Doctors: A Story of Corruption

November 18, 2008

Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach

The New York Times reports that an FDA advisory committee deliberating over the safety of using antipsychotic

Read More
Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach

April 27, 2008

Letter of Complaint Re: FDA Double Agent

  ALLIANCE FOR HUMAN RESEARCH PROTECTION www.ahrp.org 142 West End Avenue, Suite 28P New York, NY 10023

Read More
Letter of Complaint Re: FDA Double Agent